Table 3.
OR (95% CI) | p | ||
---|---|---|---|
Sex | 1.404 | (0.63–3.13) | 0.408 |
Age | 0.996 | (0.99–1.03) | 0.822 |
Clinical staging | 1.851 | (1.04–3.47) | 0.038 |
Pathological types | 1.373 | (0.96–2.48) | 0.277 |
Noncompliance with thyroxin therapy | 1.935 | (1.03–3.65) | 0.042 |
Thyroglobulin | 1.892 | (1.01–3.56) | 0.032 |
VEGF | 1.203 | (0.95–1.52) | 0.125 |